-
Sector Analysis
NewAntibody-Drug Conjugates (ADC) Overview, Industry Trends, Marketed and Pipeline Products, Opportunities and Challenges
Antibody-Drug Conjugates Market Report Overview An Antibody-Drug Conjugates (ADC) drug consists of monoclonal antibodies conjugated to a payload via a linker, for the precise targeting of antigen-positive cancer cells. ADCs are developed to target protein receptors with high expression such as HER2, TROP-2, CD22, and others. There are two cytotoxic payload types predominantly used in ADCs including microtubule inhibitors, and the more potent DNA-damaging payloads such as topoisomerase I inhibitors. The ADC market research report will aid clients in gaining...
-
Innovation Ranking
NewInnovation Ranking – Pfizer Inc
Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and pain, women’s health, cancer, inflammation, immune disorders, and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, individual provider offices, clinics, government agencies and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US....
-
Thematic Analysis
NewRegulated mHealth Apps – Thematic Intelligence
Regulated mHealth Apps Thematic Report Overview Mobile health apps, often abbreviated as mHealth apps, are software applications designed for mobile devices such as smartphones and tablets that offer various health-related functionalities. These apps cater to a wide range of needs, from general health and wellness tracking to specific medical condition management. They encourage patients to take control of their health by tracking their medical data, accessing their medical records, and communicating with healthcare providers. While there are several categories of...
-
Product Insights
NewAtopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Atopic Dermatitis Clinical Trials Market Report Overview In total, there were 2,258 clinical trials conducted on atopic dermatitis (atopic eczema), as of March 2024. The atopic dermatitis clinical trial market research report provides an overview of the Atopic Dermatitis clinical trials scenario. This report provides top-line data relating to the clinical trials on Atopic dermatitis. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease...
-
Product Insights
NewArthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Arthralgia Clinical Trial Report Overview A total of 713 Arthralgia clinical trials were conducted as of March 2024. The Arthralgia clinical trial report provides a comprehensive understanding of the Arthralgia clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·       North America ·       Europe ·       Asia-Pacific ·       ...
-
Product Insights
NewGraft Versus Host Disease (GVHD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Graft Versus Host Disease (GVHD) Clinical Trial Market Report Overview Graft versus host disease (GVHD) clinical trial market research report provides top line data relating to the clinical trials on Graft Versus Host Disease (GVHD). The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent...
-
Product Insights
NewObsessive-Compulsive Disorder Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Obsessive-Compulsive Disorder Clinical Trial Market Report Overview Obsessive-compulsive disorder clinical trial market research report provides top line data relating to the clinical trials on obsessive-compulsive disorder. The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials. Key...
-
Product Insights
NewPolycystic Kidney Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Polycystic Kidney Disease Clinical Trial Report Overview A total of 238 polycystic kidney disease clinical trials were conducted as of March 2024. The polycystic kidney disease clinical trial report provides a comprehensive understanding of the polycystic kidney disease clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions...
-
Thematic Analysis
NewRNA-Based Drugs and the Impact of COVID-19
This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements within the pharmaceutical industry in reference to RNA technology is provided, allowing you to identify and discern the key points within this area.
-
Product Insights
NewNet Present Value Model: Pfizer Inc’s Maplirpacept
Empower your strategies with our Net Present Value Model: Pfizer Inc's Maplirpacept report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.